Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Upper respiratory tract illnesses have been associated with an increased risk of ischemic heart disease and stroke. During two influenza seasons, we assessed the influence of vaccination against influenza on the risk of hospitalization for heart disease and stroke, hospitalization for pneumonia and influenza, and death from all causes. METHODS: Cohorts of community-dwelling members of three large managed-care organizations who were at least 65 years old were studied during the 1998-1999 and 1999-2000 influenza seasons. Administrative and clinical data were used to evaluate outcomes, with multivariable logistic regression to control for base-line demographic and health characteristics of the subjects. RESULTS: There were 140,055 subjects in the 1998-1999 cohort and 146,328 in the 1999-2000 cohort, of which 55.5 percent and 59.7 percent, respectively, were immunized. At base line, vaccinated subjects were on average sicker, having higher rates of most coexisting conditions, outpatient care, and prior hospitalization for pneumonia than unvaccinated subjects. Unvaccinated subjects, however, were more likely to have been given a prior diagnosis of dementia or stroke. Vaccination against influenza was associated with a reduction in the risk of hospitalization for cardiac disease (reduction of 19 percent during both seasons [P<0.001]), cerebrovascular disease (reduction of 16 percent during the 1998-1999 season [P<0.018] and 23 percent during the 1999-2000 season [P<0.001]), and pneumonia or influenza (reduction of 32 percent during the 1998-1999 season [P<0.001] and 29 percent during the 1999-2000 season [P<0.001]) and a reduction in the risk of death from all causes (reduction of 48 percent during the 1998-1999 season [P<0.001] and 50 percent during the 1999-2000 season [P<0.001]). In analyses according to age, the presence or absence of major medical conditions at base line, and study site, the findings were consistent across all subgroups. CONCLUSIONS: In the elderly, vaccination against influenza is associated with reductions in the risk of hospitalization for heart disease, cerebrovascular disease, and pneumonia or influenza as well as the risk of death from all causes during influenza seasons. These findings highlight the benefits of vaccination and support efforts to increase the rates of vaccination among the elderly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Influenza vaccination as a population-wide prevention measure was associated with a very cost-effective reduction in clinical events.171”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [171]
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Von Sternberg, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 996
Self-citationInfection and Atherosclerosis: Emerging Mechanistic Paradigms
Epstein, S. E., Zhou, Y. F., & Zhu, J. (1999) · Circulation · doi:10.1161/01.cir.100.4.e20 · Cited by 511
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
Nichol, K. L., Wuorenma, J., & von Sternberg, T. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1769 · Cited by 484
Self-citationValidation of self-report of influenza and pneumococcal vaccination status in elderly outpatients
Mac Donald, R., Baken, L., Nelson, A., & Nichol, K. L. (1999) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00159-7 · Cited by 410
Self-citationAcute respiratory-tract infections and risk of first-time acute myocardial infarction
Meier, C. R., Jick, S. S., Derby, L. E., Vasilakis, C., Jick, H., Meier, C., Jick, S., Derby, L., Vasilakis, C., & Jick, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11084-4 · Cited by 389
Vu, T., Farish, S., Jenkins, M., & Kelly, H. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00041-5 · Cited by 376
Research works printed but not linked: 7
- 2002, MMWR Morb Mortal Wkly Rep, 51, 1
- Nichol KL. Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. Oxford, England: Blackwell Science, 1998:358-72.
- Becher H, 2000, J Epidemiol Biostat, 5, 277
- 1999, MMWR Morb Mortal Wkly Rep, 48, 374
- 2000, MMWR Morb Mortal Wkly Rep, 49, 375
- 1997, MMWR Morb Mortal Wkly Rep, 46, 1
- Healthy People 2010: conference edition. Vol. 1. Washington, D.C.: Department of Health and Human Services, January 2000.
Cited by
Items 401–500 of 742
Influenza Vaccination and Risk of Ischemic Stroke: A Population-Based Case-Control Study
Rodríguez‐Martín, S., Barreira‐Hernández, D., Gil, M., García‐Lledó, A., Izquierdo-Esteban, L., & de Abajo, F. J. (2022) · Neurology · doi:10.1212/wnl.0000000000201123 · Cited by 18
“approximately 10%–15%, which started earlier and persisted over time up to the next season; (2) the reduction in risk was observed for both noncardioembolic and cardioembolic IS alike; (3) the risk reduction associated with influenza vaccination appeared to be similar in the pre-epidemic, epidemic, and post-epidemic p…”
BackgroundResultGefenaitė, G., Rahamat-Langendoen, J. C., Ambrozaitis, A., Mickienė, A., Jančorienė, L., Kuliešė, M., Vėlyvytė, D., Niesters, H. G. M., Stolk, R. P., Žagminas, K., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.12.021 · Cited by 17
Boytsov, S. A., Loukianov, М. М., Вячеславовна, П. Е., Gorbunov, V. M., Викторовна, Р. С., Назарова, О. А., Gille-Belova, O., Kravtsova, E. A., Dovgalevsky, P. Y., Фурман, Н. В., et al. (2016) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2016-12-6-703-710 · Cited by 16
Could Influenza Vaccination Prevent Myocardial Infarction, Stroke and Sudden Cardiac Death?
Meyers, D. G. (2003) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200303040-00002 · Cited by 18
Influenza vaccination in patients on long-term anticoagulant therapy
Iorio, A. M., Camilloni, B., Basileo, M., Guercini, F., Conti, S., Ferrante, F. J., Paccamiccio, E., Iaboni, S., Vecchioli, M., & Iorio, A. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.036 · Cited by 16
Shapiro, Y., Shemer, J., Heymann, A. D., Shalev, Maharshak, N., Chodik, G., Green, M. S., & Kokia, E. S. (2003) · PubMed · Cited by 16
Kurtz, P., Bastos, L. D. S. L., Aguilar, S., Hamacher, S., & Bozza, F. A. (2020) · International Journal of Stroke · doi:10.1177/1747493020947333 · Cited by 15
“Stroke has also been associated with bacterial and viral respiratory infections, which are more common in winter months.(13,14) The strengths of our study include the nationally representative large sample of patients and the long period of 10 years of data collection.”
BackgroundDhont, P., Albert, A., Brenders, P., Podwapinska, A., Pollet, A., Scheveneels, D., Tihon, F., Verheyden, I., Victor, J., & Samson, S. (2012) · Advances in Therapy · doi:10.1007/s12325-012-0025-9 · Cited by 16
Vaccines for Women Age 50 and Older1
Gardner, P., & Pabbatireddy, S. (2004) · Emerging Infectious Diseases · doi:10.3201/eid0703.040469 · Cited by 15
Workshop on Immunizations in Older Adults: Identifying Future Research Agendas
High, K. P., D’Aquila, R. T., Fuldner, R., Gerding, D. N., Halter, J. B., Haynes, L., Hazzard, W. R., Jackson, L. A., Janoff, E. N., Levin, M. J., et al. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02772.x · Cited by 16
“A few studies suggest that vaccines can significantly reduce this risk.(10,11) A major objective of preventive interventions in older adults is the reduction of catastrophic disability, defined as loss of independence in three or more activities of daily living (ADLs).”
BackgroundSelf-citationMeschia, J. F., Bushnell, C., Boden-Albala, B. M., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Fornage, M., Goldstein, L. B., et al. (2014) · Cited by 15
Hsu, S.-Y., Chen, F., Liaw, Y., Huang, J., Nfor, O. N., & Chao, D. (2016) · Medicine · doi:10.1097/md.0000000000002869 · Cited by 15
Poscia, A., Collamati, A., Carfì, A., Topinková, E., Richter, T., Denkinger, M. D., Pastorino, R., Landi, F., Ricciardi, W., Bernabei, R., et al. (2017) · European Journal of Public Health · doi:10.1093/eurpub/ckx150 · Cited by 16
Liu, Y., Gong, P., Wang, M., & Zhou, J. (2018) · Chronobiology International · doi:10.1080/07420528.2017.1369430 · Cited by 17
“Cohort studies showed that influenza vaccination was associated with reduced risk of stroke (Grau et al. 2005; Nichol et al. 2003).”
BackgroundKee, S. Y., Cheong, H. J., Chun, B. C., & Kim, W. J. (2011) · Infection and Chemotherapy · doi:10.3947/ic.2011.43.5.406 · Cited by 15
Vaccines in Development to Prevent and Treat Atherosclerotic Disease
Riley, E., Dasari, V. M., Frishman, W. H., & Sperber, K. E. (2008) · Cardiology in Review · doi:10.1097/crd.0b013e3181885933 · Cited by 15
“In looking at overall risk, Nichol et al looked at 288,238 community-dwelling elderly persons ( 65 years old).(86) During the respective flu seasons, 55.”
BackgroundNeigh, G. N., Glasper, E. R., Bilbo, S. D., Traystman, R. J., & DeVries, A. C. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600137 · Cited by 15
“Journal of Cerebral Blood Flow & Metabolism (2005) 25, 1424–1432 Lavallee et al, 2002; Nichol et al, 2003; Siscovick et al, 2000), but does not reduce the risk of recurrent coronary events after myocardial infarction (Jackson et al, 2002).”
BackgroundResultInfluentialJiménez‐García, R., Hernández‐Barrera, V., Carrasco‐Garrido, P., del Pozo, S. V.-F., & de Miguel, Á. G. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.036 · Cited by 15
Optimal control of an influenza model with mixed cross-infection by age group
Ya, C., Zhang, J., & Jin, Z. (2022) · Mathematics and Computers in Simulation · doi:10.1016/j.matcom.2022.11.019 · Cited by 14
Role of Influenza Vaccination in Cardiovascular Disease: Systematic Review and Meta-Analysis
Gupta, R., Quy, R., Lin, M., Mahajan, P., Malik, A., Sood, A., Sreenivasan, J., Bandyopadhyay, D., Goel, A., Agrawal, A., et al. (2023) · Cardiology in Review · doi:10.1097/crd.0000000000000533 · Cited by 12
Fattore, G., Pongiglione, B., & Vezzosi, L. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09071-z · Cited by 16
“%) for heart and cardiovascular diseases [12].”
SARS-CoV-2 and myocardial injury: Few answers, many questions
Cremer, P. C. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc001 · Cited by 15
Is it worth offering cardiovascular disease prevention to the elderly?
Gohlke, H. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711430384 · Cited by 14
“Risk of death in two observation periods was reduced by almost 50%, independently of major medical conditions at baseline and consistently across all subgroups.(29) The direct costs per gained life year in persons above age 65 were as low as US $10–12 per year, compared with statins where a year of extended life may c…”
BackgroundInfluenza Vaccination: A Collaborative Effort to Improve the Health of the Community
Parry, M. F., Grant, B., Iton, A. B., Parry, P. D., & Baranowsky, D. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502322 · Cited by 14
Liu, Y., Huang, L., & Wang, J. (2004) · Journal of Occupational Health · doi:10.1539/joh.46.455 · Cited by 14
Tsai, Y., Huang, W.-F., Wen, Y., & Chen, P. (2007) · Value in Health · doi:10.1111/j.1524-4733.2006.00158.x · Cited by 14
Influenza Vaccination Rate and Reasons for Nonvaccination in Children With Cardiac Disease
Livni, G., Wainstein, A., Birk, E., Chodick, G., & Levy, I. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001579 · Cited by 14
Müller‐Werdan, U. (2007) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-007-0486-7 · Cited by 14
Preventing Pneumonia: The Role for Pneumococcal and Influenza Vaccines
Shorr, A. F. (2005) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2004.10.003 · Cited by 18
“The largest multiseasonal study was completed by Nichol et al [67].”
BackgroundInfluentialJordan, R., Hawker, J. I., Ayres, J. G., Tunnicliffe, W. S., Adab, P., Olowokure, B., Kai, J., McManus, R. J., Salter, R., & Cheng, K. K. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.09.005 · Cited by 14
Management of Chronic Obstructive Pulmonary Disease
Khdour, M. R., Hallak, H., & Abdeen, H. (2019) · Handbook of Healthcare in the Arab World · doi:10.1001/jama.291.9.1066-a · Cited by 113
Benefits of Examining Influenza Vaccine Associations Outside of Influenza Season
Jackson, L. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200805-805ed · Cited by 14
Burad, J., Bhakta, P., George, J., & Kiruchennan, S. (2012) · Acta anaesthesiologica Taiwanica · doi:10.1016/j.aat.2012.02.002 · Cited by 13
Rural Disparities in Alzheimer's Disease‐Related Community Pharmacy Care in the United States
Henkel, P. J., & Marvanová, M. (2017) · The Journal of Rural Health · doi:10.1111/jrh.12279 · Cited by 15
Shih, C.-H., Lee, Y.-J., Chao, P.-W., Kuo, S., Ou, S., Huang, H., & Chen, Y. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.04.020 · Cited by 13
Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, r Ov -ASP-1
Jiang, J. K., Fisher, E. M., Concannon, M., Lustigman, S., Shen, H., & Murasko, D. M. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.01.003 · Cited by 14
Multiple Myeloma Vaccination Patterns in a Large Health System: A Pilot Study
Alemu, A., Singh, M., Blumberg, C., Richards, J. O., Oaks, M. K., & Thompson, M. A. (2017) · Journal of patient-centered research and reviews · doi:10.17294/2330-0698.1415 · Cited by 13
“15 15-17 Yet, FV is routinely recommended for most adults, particularly those with chronic respiratory, cardiac and renal disease as well as those with underlying immune suppression such as patients on active cancer and immunosuppressive medications.”
Perspective Review : Type 2 Diabetes and Readmission for Heart Failure
Thomas, M. C. (2018) · Clinical Medicine Insights Cardiology · doi:10.1177/1179546818779588 · Cited by 16
Zhang, H. T., McGrath, L. J., Ellis, A. R., Wyss, R., Lund, J. L., & Stürmer, T. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwz083 · Cited by 13
Kulick, E. R., Canning, M., Parikh, N. S., Elkind, M. S. V., & Boehme, A. K. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016213 · Cited by 13
Façanha, M. C. (2005) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132005000500009 · Cited by 13
Arnoux, S., Weinberger, C., & Gessner, B. D. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.08.063 · Cited by 13
Epidemiology and outcomes of hospitalization of influenza in the cancer population in Taiwan
Tai, Y., Lee, T.-C., Chang, H.-L., & Chen, K. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0545-0 · Cited by 13
“…National Defense Medical Center, National Defense University, Taipei, Taiwan for hospitalization for pneumonia and inXuenza (Wang et al. 2002) and chronic diseases (Nichol et al. 2003; Colquhoun et al. 1997), as well as for hospitalization of persons in high-risk groups (O’Reilly and Stevens 2002).”
BackgroundCost effectiveness of influenza vaccination in patients with acute coronary syndrome in Korea
Suh, J., Kim, B., Yang, Y., Suh, D., & Kim, E. Y. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.016 · Cited by 13
“Therefore, the influenza vaccination is important because it decreases the risk of hospitalization and mortality for heart disease [6].”
BackgroundImmunofitness in the elderly: The role of vaccination in promoting healthy aging
Rial, J. G., Redondo, E., Calle, I. R., Mascarós, E., Ocaña, D., Jimeno, I., Gil, A., Linares, M., Onieva-García, M. Á., González‐Romo, F., et al. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2624234 · Cited by 14
Chang, Y.-C., Tung, H., Huang, Y., Lu, C.-T., Ernawaty, E., & Wu, S. (2020) · Vaccines · doi:10.3390/vaccines8010112 · Cited by 12
“1), heart diseases (ICD-9-CM codes 410–429), hemorrhagic stroke (ICD-9-CM 430, 431, and 432), and ischemic stroke (ICD-9-CM 433 and 434) [11,12].”
BackgroundHara, M., Sakamoto, T., & Tanaka, K. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.035 · Cited by 12
Prevención de la neumonía del adulto adquirida en la comunidad
Manuel Barros, M., Claudia Cartagena, S., & Luis Bavestrello, F. (2005) · Revista chilena de infectología · doi:10.4067/s0716-10182005000400009 · Cited by 13
Improving seasonal and pandemic influenza vaccines
Saville, M. K., Marsh, G., & Hoffenbach, A. (2008) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2008.00060.x · Cited by 14
Assink, M. D. M., Kiewiet, J. P., Rozenbaum, M. H., van den Berg, P. B., Hak, E., Buskens, E., Wilschut, J., Kroes, A. C. M., & Postma, M. J. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.070 · Cited by 12
“Some further recent studies suggest that there might also be an association between cardiovascular problems and influenza epidemics among groups without any cardiovascular history yet, such as the elderly or even among those aged below 65 years of age [23,35].”
BackgroundBaio, G., Pammolli, F., Baldo, V., & Trivello, R. (2006) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.6.3.293 · Cited by 17
Community‐acquired pneumonia: Defining quality care
Seymann, G. (2006) · Journal of Hospital Medicine · doi:10.1002/jhm.128 · Cited by 12
“Among the elderly, reduction in mortality of about 50% has been reported, along with 20%-30% reductions in hospitalizations for pneumonia, influenza, cardiac disease, and stroke.(70) Reduced incidence of pneumonia in vaccinated patients has even been documented among elderly patients without specific comorbidities.”
BackgroundYoung, A., Tordoff, J. M., Dovey, S. M., Reith, D. M., Lloyd, H., Tilyard, M., & Smith, A. J. (2016) · JMIR Research Protocols · doi:10.2196/resprot.5543 · Cited by 14
Vaccinations for the Older Adult
Gnanasekaran, G., Biedenbender, R., Davidson, H. E., & Gravenstein, S. (2016) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.03.001 · Cited by 13
Management of respiratory infections in the elderly
Lieberman, D. B., & Lieberman, D. (2003) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.1.3.505 · Cited by 15
Hao, W., Yang, T., Lai, Y.-H., Lin, K.-J., Fang, Y.-A., Chen, M., Hsu, M., Chiu, C.-C., Yang, T.-Y., Chen, C., et al. (2023) · Vaccines · doi:10.3390/vaccines11061098 · Cited by 12
“In a study by Kristin, influenza vaccination in the elderly was associated with reduced risk of hospitalization for heart disease and cerebrovascular disease [17].”
BackgroundGeier, D. A., Kern, J. K., Homme, K. G., & Geier, M. R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190894 · Cited by 11
“In the context of influenza vaccination of older adults and the elderly, this type of phenomena may have been observed when it was reported that the risk of death from all causes was about 50% lower in persons receiving influenza vaccination as compared to persons not receiving influenza vaccination [52].”
ResultStroke and neurointervention in the COVID-19 pandemic: a narrative review
Rana, A., Nguyen, T. N., & Siegler, J. E. (2021) · Expert Review of Medical Devices · doi:10.1080/17434440.2021.1928495 · Cited by 13
“good hygiene) and with vaccination against influenza [37].”
BackgroundVollmer, B. L., Solowey, J. R., Chen, X., Chang, B., Williams, O. A., Kulick, E. R., Elkind, M. S. V., & Boehme, A. K. (2022) · Stroke · doi:10.1161/strokeaha.121.038403 · Cited by 11
Vaccination in the prevention of infectious respiratory diseases in adults
Lundgren, F. L. C., Maranhão, B., Martins, R. L. D. M., Chatkin, J. M., Rabahi, M. F., Corrêa, R. D. A., de Figueiredo, M. R. F., de Andrada, N. C., & Stirbulov, R. (2014) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.60.02.004 · Cited by 11
del Pozo, S. V.-F., Hernández‐Barrera, V., Carrasco‐Garrido, P., de Miguel, Á. G., & Jiménez‐García, R. (2007) · Gaceta Sanitaria · doi:10.1157/13099114 · Cited by 11
Appropriateness of antiviral prescribing for influenza in primary care: a retrospective analysis*
Linder, J. A., Chan, J. C., & Bates, D. W. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00731.x · Cited by 11
“Race and ethnicity ‘Other’ was not recorded (20), Asian (3), and other (1).”
BackgroundPiercy, J., Ryan, J. A., & Megas, F. (2004) · Journal of Medical Economics · doi:10.3111/200407001018 · Cited by 11
Ourti, T. V., & Bouckaert, N. (2020) · European Journal of Public Health · doi:10.1093/eurpub/ckaa016 · Cited by 12
Chávarri, H. S., Carbonell, V. P., López, J. L. O., Beltrán, D. O., Gil-Guillén, V. F., & Climent, M. A. P. (2004) · Atención Primaria · doi:10.1016/s0212-6567(04)79512-8 · Cited by 14
Vaccination for atherosclerosis: a novel therapeutic paradigm
Shah, P. K., Chyu, K., Fredrikson, G. N., & Nilsson, J. Å. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.6.711 · Cited by 11
Rising utilization of US emergency departments: Maybe it is time to stop blaming the patients
Schull, M. J. (2004) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.09.027 · Cited by 11
Neurologic Complications of Influenza and Potential Protective Vaccine Effects
Falsey, A. R. (2025) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.70071 · Cited by 11
Chan, C. Y. Y., Low, J. G. H., Wyone, W., Oon, L. L. E., & Tan, B. H. (2018) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v47n11p445 · Cited by 10
“Regurgitation 34 (18) 3 (12) 31 (18) 0.”
Crossley, K., & Peterson, P. K. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00314-3 · Cited by 10
Vacunación antigripal en personas mayores
Chaín, G. M., Lázaro, A. M., Pérez, F. A., & Bravo, C. V. (2011) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2010.10.003 · Cited by 12
Efetividade da vacina contra influenza em idosos em Porto Alegre
Prass, L., Menezes, H. S., Abegg, M. P., Gomes, M. B., de Souza, W. C., & Cirino, S. L. M. B. (2010) · Cited by 11
Богачевская, С. А., & Николаевич, Б. А. (2017) · Social Aspects of Population Health · doi:10.21045/2071-5021-2017-53-1-1 · Cited by 10
Bacurau, A. G. D. M., Ferraz, R. D. O., Donalísio, M. R., & Francisco, P. M. S. B. (2019) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00145117 · Cited by 14
Rezaei, N., Kheiri, S., Dehghani, M., & Mohammadian-Hafshejani, A. (2023) · BioMed Research International · doi:10.1155/2023/2606854 · Cited by 13
“Eight of the studies were case-control studies [24, 29, 31, 37, 39, 40, 43, 44], and six studies were performed as cohorts [30, 38, 41, 42, 45, 46].”
BackgroundVacina contra o vírus da influenza e mortalidade por doenças cardiovasculares na cidade de São Paulo
Mansur, A. D. P., Favarato, D., & Ramires, J. A. F. (2009) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2009001000013 · Cited by 10
Cost Effectiveness of Diabetes Mellitus Management Programs: A Health Plan Perspective
Gilmer, T., & O’Connor, P. J. (2003) · Disease Management & Health Outcomes · doi:10.2165/00115677-200311070-00004 · Cited by 10
Late influenza vaccination is associated with reduced effectiveness
Chodick, G., Heymann, A. D., Green, M. S., Kokia, E. S., & Shalev, V. (2006) · Preventive Medicine · doi:10.1016/j.ypmed.2006.02.009 · Cited by 10
Death and serious illness following influenza vaccination: a multidisciplinary investigation
Rue, A., Iskander, J. K., Lyn, S., Burwen, D. R., Gargiullo, P. M., Shadomy, S. V., Blostein, J., Bridges, C. B., Haber, P., Satzger, R. D., et al. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1743 · Cited by 10
de la Fuente, R. L., Gurfinkel, E., Toledo, D., & Mautner, B. (2003) · Revista Española de Cardiología · doi:10.1016/s0300-8932(03)76991-7 · Cited by 10
Landi, F., Onder, G., Cesari, M., Russo, A., Barillaro, C., Bernabei, R., Gambassi, G., Manigrasso, L., Pagano, F., & Gobbi, C. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.02.017 · Cited by 11
Déclaration sur la vaccination antigrippale pour la saison 2011–2012
(CCNI), C. C. N. D. L. (2011) · Relevé des maladies transmissibles au Canada · doi:10.14745/ccdr.v37i00a05f · Cited by 14
Muñoz-Torrero, J. F. S., Saponi-Cortes, J. M. R., Descante, C. O., Escribano, I. O. G., Sánchez, T. S., Reyes, F. P., Ruiz, C. M., & Campoamor, A. C. (2003) · Revista Clínica Española · doi:10.1016/s0014-2565(03)71294-6 · Cited by 10
Influenza vaccination and risk of dementia: a systematic review and meta-analysis
Yang, W., Shao, S., Liu, C.-C., & Chi, C. (2025) · Age and Ageing · doi:10.1093/ageing/afaf169 · Cited by 12
The effect of influenza vaccination on the rate of dementia amongst older adults
Appel, A. M., Janbek, J., Jensen‐Dahm, C., Laursen, T. M., & Waldemar, G. (2024) · European Journal of Neurology · doi:10.1111/ene.16489 · Cited by 9
An Update on Chronic Obstructive Pulmonary Disease
Pleasants, R. A., & Haden, D. W. (2005) · The Consultant Pharmacist · doi:10.4140/tcp.n.2005.965 · Cited by 9
Upper Respiratory Tract Infections
Mossad, S. B. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6643-9.00109-0 · Cited by 9
Keshtkar‐Jahromi, M., Ouyang, M., Keshtkarjahromi, M., Almed, S., Li, H., Walston, J. D., Rios, R., & Leng, S. X. (2018) · Vaccine · doi:10.1016/j.vaccine.2017.11.045 · Cited by 9
Health and care needs of patients with stroke applied to home health service
Kaya, Ç. A., Mercan, E., & Çifçili, S. (2018) · The Journal of Turkish Family Physician · doi:10.15511/tjtfp.18.00369 · Cited by 9
“Oysa hem 65 yaş üzeri bireylere hem de kronik hastalığı olan bireylere yıllık influenza aşısı ile pnömokok aşısı önerilmektedir.(14,15)”
Improving the simple, complicated and complex realities of community-acquired pneumonia
Liu, S. K., Homa, K. A., Butterly, J. R., Kirkland, K. B., & Batalden, P. B. (2009) · BMJ Quality & Safety · doi:10.1136/qshc.2008.028514 · Cited by 9
Prevention of Postoperative Pneumonia
Kollef, M. H. (2007) · Cited by 9
The hospitalization burden of influenza: just the tip of the iceberg?
Bertolani, A., Fattore, G., & Pregliasco, F. E. (2018) · Global & Regional Health Technology Assessment · doi:10.1177/2284240318777148 · Cited by 9
Sribhutorn, A., Phrommintikul, A., Wongcharoen, W., Chaikledkaew, U., Eakanunkul, S., & Sukonthasarn, A. (2018) · PubMed Central · doi:10.11909/j.issn.1671-5411.2018.06.008 · Cited by 9
Effect of seasonal variation on the frequency of incident stroke hospitalizations in Scotland
Sharma, N., Moinuddin, A., Lewsey, J., & Inglis, S. C. (2015) · Saudi Journal for Health Sciences · doi:10.4103/2278-0521.151405 · Cited by 9
Rationalizing recommendations for influenza and COVID-19 vaccines
Breznik, J. A., Miller, M. S., & Bowdish, D. M. E. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127775 · Cited by 9
Cost and utilization avoidance with mail prompts: a randomized controlled trial.
Berg, G. D., Silverstein, S. M., Thomas, E., & Korn, A. M. (2008) · PubMed · Cited by 8
Violi, F., Calvieri, C., & Cangemi, R. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-019-02117-0 · Cited by 8
Chang, Y.-C., Huang, Y., Chen, L., Tung, H., Huang, K., Ernawaty, E., & Wu, S. (2020) · Vaccines · doi:10.3390/vaccines8010140 · Cited by 8
“1), heart diseases (ICD-9-CM codes 410-429), hemorrhagic stroke (ICD-9-CM 430, 431, or 432), and ischemic stroke (ICD-9-CM 433 or 434) [8,9] during the studied influenza season.”
Obesity, Cardiovascular Disease, and Influenza: How Are They Connected?
Gutiérrez-Spillari, L., Geovani Palma, M., & Aceituno-Melgar, J. E. (2020) · Current Tropical Medicine Reports · doi:10.1007/s40475-020-00207-0 · Cited by 9
Impact of Influenza Immunization on Medical Expenditures Among Medicare Elderly, 1999–2003
Gilman, B. H., Bonito, A. J., & Eicheldinger, C. R. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.10.010 · Cited by 10
Metadata
- Authors
- Nichol, K. L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., & Iwane, M.
- Affiliations
- University of Minnesota (US)
- HealthPartners (US)
- Kaiser Permanente (US)
- Centers for Disease Control and Prevention (US)
- ORCID
- Nordin, James
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-03
- Volume
- 348
- Issue
- 14
- Pages
- 1322-1332
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2116971894
- Cited by
- 752
- References
- 42
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 10 · 2023: 15 · 2022: 14 · 2021: 17 · 2020: 23 · 2019: 26 · 2018: 29 · 2017: 25 · 2016: 19 · 2015: 33 · 2014: 29 · 2013: 42 · 2012: 50
- FWCI
- 45.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- influenza vaccination, influenza, stroke, heart disease, hospitalization, older adults, pneumonia, mortality, ischemic heart disease, cerebrovascular disease, upper respiratory tract infection, managed care, community-dwelling older adults, vaccine effectiveness, dementia, comorbidities, subgroup analysis
- MeSH terms
- Aged, Aged, 80 and over, Female, Heart Diseases, Hospitalization, Humans, Influenza, Human, Influenza Vaccines, Male, Mortality, Pneumonia, Risk, Logistic Models, Odds Ratio, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.